The global CRISPR gene editing market was valued at over $1 billion in 2021 and is predicted to reach USD 14.80 billion by 2030, increasing at a CAGR of 29.80% from 2022 to 2030. This dramatic rise comes from a growing prevalence of genetic diseases globally, increasing applications of gene editing in various industries and growing awareness of gene editing technology in developing countries. However, stringent government regulations may hinder the industries expansion.
The Future of Gene Editing
